|Bid||52.08 x 1000|
|Ask||52.09 x 2900|
|Day's Range||52.01 - 52.27|
|52 Week Range||41.60 - 53.05|
|PE Ratio (TTM)||N/A|
|Expense Ratio (net)||0.11%|
A foundation I work with asked me to compare its performance with that of other foundations using the most recent data available. The news was quite good. This relatively small foundation (“Foundation X”) managed to beat the return averages for all size foundations and even the top 10 percentile of performance of all foundations. Yet it is the story of how it achieved this that is most compelling, as any individual or foundation can do the same.
Market-cap weighting is often a good choice for indexing, but in some markets it may compromise diversification.
AstraZeneca's (AZN) Respiratory segment is one its key growth platforms. The segment reported nearly flat revenue of $1.2 billion at constant exchange rates in 1Q17.